Whiplashed investors stay skittish about St. Jude

One day after a short seller claimed that St. Jude Medical Inc’s (STJ.N) heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude’s $24 billion planned deal for Abbott Labs (ABT.N)... More »